Table 1: Baseline characteristics of NSCLC patients with/without BM.
|
|
Without BM (N=255) |
With BM (n=52) |
p |
Age (year) |
Median (range) |
62 (25-83) |
62.5 (43-78) |
0.92 |
BMI (kg/m²) |
Median (range) |
23.18 (16-34) |
22.85 (14-30) |
0.088 |
Sex |
Male (%) |
154 (60.4%) |
31 (59.6%) |
0.92 |
Smoking |
Yes (%) |
157 (61.6%) |
35 (67.3%) |
0.436 |
Hypertension |
Yes (%) |
105 (41.2%) |
25 (48.1%) |
0.359 |
Diabetes |
Yes (%) |
59 (23.1%) |
9 (17.3%) |
0.37 |
Yes (%) |
16 (6.3%) |
2 (3.8%) |
0.748 |
|
Primary tumor size (cm) |
Median (range) |
3 (0.4-14) |
3.6 (0.8-11) |
0.912 |
Primary tumor location (lobe) |
Upper (%) |
152 (59.6%) |
26 (50.0%) |
0.02 |
Lower (%) |
89 (34.9%) |
17 (32.7%) |
||
Middle (%) |
14 (5.5%) |
9 (17.3%) |
||
Histology (type) |
Adenocarcinoma (%) |
180 (70.6%) |
46 (88.5%) |
0.028 |
Squamous carcinoma (%) |
58 (22.7%) |
5 (9.6%) |
||
Other (%) |
17 (6.7%) |
1 (1.9%) |
||
CI |
Yes (%) |
160 (62.7%) |
44 (84.6%) |
0.002 |
T status |
T3-T4 (%) |
74 (29.0%) |
28 (53.8%) |
0.001 |
LN status |
N2-N3 (%) |
134 (52.5%) |
42 (80.8%) |
<0.001 |
D-D (ng/ml) |
Median (range) |
182 (0.11-14612) |
304.5 (52-7640) |
<0.001 |
CEA (ng/ml) |
Median (range) |
4.11 (0.1-746.7) |
9.675 (1.28-1068) |
<0.001 |
CA125 (U/ml) |
Median (range) |
19.44 (3.1-2846) |
49.15 (6.61-796.7) |
<0.001 |
CYFRA21-1 (ng/ml) |
Median (range) |
21.93 (0.3-971) |
28.56 (1.36-978) |
0.23 |
BM: brain metastasis; BMI: body mass index; CI: cerebral infarction; D-D: D-Dimer; CEA: carcinoembryonic antigen; CA125: carbohydrate antigen 125; CYFRA21-1: cytokeratin 19 fragment.